This study is to evaluate the dosimetric impact of dosimetric leaf gap (DLG) and transmission factor (TF) at different measurement depths and field sizes for high definition multileaf collimator (HD MLC). Consequently, its clinical implication on dose calculation of treatment planning system was also investigated for pancreas stereotactic body radiation therapy (SBRT). The TF and DLG were measured at various depths (5, 8, 10, 12, and 15 cm) and field sizes (6×6, 8×8, and 10×10 cm 2 ) for various energies (6 MV, 6 MV FFF, 10 MV, 10 MV flattening filter free [FFF], and 15 MV). Fifteen pancreatic SBRT cases were enrolled in the study. For each case, the dose distribution was recomputed using a reconfigured beam model of which TF and DLG was the closest to the patient geometry, and then compared to the original plan using the results of dose-volume histograms (DVH). For 10 MV FFF photon beam, its maximum difference between 2 cm and 15 cm was within 0.9% and it is increased by 0.05% from 6×6 cm 2 to 10×10 cm 2 for depth of 15 cm. For 10 MV FFF photon beam, the difference in DLG between the depth of 5 cm and 15 cm is within 0.005 cm for all field sizes and its maximum difference between field size of 6×6 cm 2 and 10×10 cm 2 is 0.0025 cm at depth of 8 cm. TF and DLG values were dependent on the depth and field size. However, the dosimetric difference between the original and recomputed doses were found to be within an acceptable range (＜0.5%). In conclusion, current beam modeling using single TF and DLG values is enough for accurate dose calculation.
Introduction
Advanced radiation therapy techniques such as intensitymodulated radiation therapy (IMRT), volumetric arc therapy (VMAT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT) have been widely used because they minimize the probability of complications to normal tissue while maximizing tumor control. [1] [2] [3] The multileaf collimator (MLC) plays a key role in such advanced radiation therapy for delivering the spatially varied complex pattern of radiation fluence with high accuracy. 4, 5) Consequently, for accurate computation of the radiation dose delivered by the MLC, accurate dosimetric modeling of the MLC such as that of its leaf transmission factor (TF) and dosimetric leaf gap (DLG) should be included in the treatment planning system (TPS). 6) Several investigators have studied the impact of plan and dosimetric distribution according to the width and shape of the leaf and the leaf speed. [7] [8] [9] They have investigated the impact of the DLG on the dose distribution and calculation by using the Millennium 120 MLC (Varian Medical Systems, Palo, Alto, CA, USA) under only one fixed depth. [10] [11] [12] [13] [14] [15] It was shown that the DLG value was different from the value measured at 
Materials and Methods

Patient characteristics
This study involved 15 patients (with pancreatic cancer) treated with SBRT from March 2015 to April 2016 at our institution (Table 1) Fig. 2(a) shows the TF values measured for the field size of 10×10 cm 2 at four different depths (2, 5, 10, and 15 cm) and Table   2 , Fig. 3 ). 
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Dosimetric leaf gap (DLG)
Discussion
We evaluated the dosimetric impact of the DLG at different depths and field sizes on an HDMLC. Its clinical implication on the dose calculation of the TPS was also investigated for SBRT in pancreatic cancer treatment.
For all photon beam energies, the TF and DLG values increased with an increase in the depth and field size (Fig. 2) .
However, we confirmed that the values of the two parameters did not significantly change as the measurement depth increased for photon beam energies of 10 MV and 15 MV. This result is consistent with a previous study on the DLG in the Millennium 120 MLC. 14) With regard to the 6 MV and 15
MV photon beams, the results are similar to those reported by Wasbø et al. 15) The increase in the TF and DLG as a function of depth is likely caused by the larger phantom scatter. As shown in Fig. 3 , the two parameters increased with an increase in the field size when the 10 MV FFF photon beam was used.
This result is consistent with the previous study 15) and the increase in the TF and DLG according to the field size is likely caused by the increase in collimator scatter.
As a result, we confirmed that TF and DLG values according to changes in the tumor depth and size should be applied to the TPS when SBRT in pancreatic cancer treatment is performed with a 10 MV FFF photon beam. Furthermore, we compared the DVHs between the original and modified plan (Fig. 4) . The dosimetric discrepancies between the two plans were found to be within an acceptable range for all depths.
Therefore, we confirmed that the change in the TF and DLG as a function of depth does not need to be considered in a TPS even though the TF and DLG values are dependent on the depth and field size.
This study focused on pancreatic cancer. In future work, this dosimetric impact will be studied for head, neck, and skin cancer that is at a relatively shallow depth to verify that the dosimetric discrepancies between the two plans are similar to that in the pancreatic case, even though the TF and DLG vary with depth and field size. Furthermore, the TF and DLG will be measured at other gantry angles to correct for the variation in this angle, which was not done in this study. In the future, dosimetric accuracy will be studied with the corrected TF and DLG in VMAT plans.
Conclusion
We have evaluated the dosimetric impact of the measured TF and DLG at different depths and field sizes on an HDMLC for SBRT in pancreatic cancer treatment. The TF and DLG were found to vary with the depth and field size.
However, the dosimetric difference between the original and recomputed doses was found to be within an acceptable range (＜0.5%). Therefore, current beam modeling using single TF
and DLG values is sufficient for accurate dose calculation, even though the TF and DLG vary with depth and field size.
